Company page
Lipigon Pharmaceuticals Ab
Lipigon Pharmaceuticals Ab is a public company listed on the Swedish market under the ticker LPGO. The company has a market capitalization of approximately 174 million SEK. Lipigon focuses on developing innovative therapies for lipid-related diseases.
- Ticker
- LPGO:OMXSTO
- Asset type
- Stock
- Market cap
- $174,073
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- OMXSTO
- Currency
- SEK